AZV – Evropská partnerství: PerMed výzva "Test and Demonstration of Multimodal Data Approaches for Personalised Medicine“ (MultiPMData2026)
AZV has announced the transnational call of the European Partnership PerMed RITC2026 (Research, Innovation and Technology Call 2026): Test and Demonstration of Multimodal Data Approaches for Personalised Medicine "MultiPMData2026".
MultiPMData2026
- Deadline for pre-proposals: January 12, 2026 (deadline for full proposals: April 27, 2026)
- International information webinar: October 28, 2025 (10:00–12:00), registration required
- Budget allocated for the Czech Republic: EUR 250,000; maximum funding per project from CZ: EUR 125,000
- Project duration: 3 years
- Transnational project consortia must include: a clinical partner and at least one partner from SMEs or industry representatives
- The consortium must include at least 3 partners from 3 different EU Member States or associated countries participating in this call (list of participating countries available on SharePoint VaV)
- Extensive clinical trials will not be supported under this call
- Projects should address at least one of the following aspects:
Identification or characterization of co-occurring diseases in patients with chronic conditions
• Diagnosis or monitoring of disease progression, including periods of improvement and relapse
• Support for transitioning from inpatient to outpatient care through remote monitoring or reporting using wearable devices or other technical tools
• Decision-making support in the selection of treatment strategies (e.g., type and dosage of treatment)
• Monitoring and management of multiple treatment strategies (including drug combinations) to improve treatment effectiveness or reduce the risk of side effects and harmful drug interactions
• Ensuring adherence to long-term treatment regimens